Skip to main content
Clinical Trials/NCT06365775
NCT06365775
Not yet recruiting
Not Applicable

Multi-omics Characteristics and Prognosis in Patients With Idiopathic Sudden Sensorineural Hearing Loss

Dan Bing0 sites400 target enrollmentApril 23, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sudden Sensorineural Hearing Loss
Sponsor
Dan Bing
Enrollment
400
Primary Endpoint
Pure tone audiometry (PTA)
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to describe the multi-omics characteristics and to learn about the prognostic factors in patients with idiopathic sudden sensorineural hearing loss (SSNHL). The main problems it aims to deal with are:

  • if there is a difference in data of exome and targeted sequencing among patients with SSNHL affecting bilateral and unilateral sides, and healthy controls
  • if there is a difference in the parameter of MRI among patients with SSNHL affecting bilateral and unilateral sides, and healthy controls
  • to find out which factor from multi-omics data relates to outcomes of SSNHL
  • to develop the best prognostics model based on the multi-omics data.

Participants will be received audiological tests, blood specimen collection and radiological examination. Researchers will explore the relationship between the multi-omics data and the prognosis and develop the predictive model.

Registry
clinicaltrials.gov
Start Date
April 23, 2024
End Date
November 23, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dan Bing
Responsible Party
Sponsor Investigator
Principal Investigator

Dan Bing

associate professor

Tongji Hospital

Eligibility Criteria

Inclusion Criteria

  • Participants with SSNHL: unilateral or bilateral sensorineural hearing loss of \> 30 dB HL (decibel) involving at least 3 continuous test frequencies developing within 72 hours
  • Healthy controls: people with PTA thresholds of all test frequencies ≤ 20 dB HL and without otologic disease in the last 3 months
  • Completed informed consent and promised to finish follow-ups

Exclusion Criteria

  • Hearing loss with explicit causes, including noise-induced, Ménière's disease, ototoxicity exposure, mumps infection or history of syphilis infection and so on.
  • A history of head trauma or otologic surgery.
  • Malformation of temporal bone discovered by computed tomography (CT)
  • Retro-cochlear lesion discovered by magnetic resonance imaging (MRI)
  • Pregnant women

Outcomes

Primary Outcomes

Pure tone audiometry (PTA)

Time Frame: Baseline, 14 days, 1, 3 and 6 months follow-ups

Pure tone thresholds of 250, 500, 1000, 2000, 4000, 8000 Hz will be measured.

Secondary Outcomes

  • Speech reception thresholds(Baseline, 14 days, 1, 3 and 6 months follow-ups)
  • Speech discrimination scores(Baseline, 14 days, 1, 3 and 6 months follow-ups)

Similar Trials